Literature DB >> 25703151

Intrinsic and extrinsic risk factors for nonunion after nonoperative treatment of midshaft clavicle fractures.

W Liu1, J Xiao2, F Ji3, Y Xie1, Y Hao1.   

Abstract

BACKGROUND: The optimal treatment of midshaft clavicle fractures remains controversial. Nonunion is usually considered to be an uncommon complication following a nonoperatively treated clavicle fracture. HYPOTHESIS: Not every midshaft clavicular fractures shares the same risk of developing nonunion after nonoperative treatment. The present study was performed to identify the intrinsic and extrinsic independent factors that are independently predictive of nonunion in patients with midshaft clavicular fractures after nonoperative treatment.
MATERIALS AND METHODS: We performed a retrospective study of a series of 804 patients (391 men and 413 women with a median age of 51.3 years) with a radiographically confirmed midshaft clavicle fracture, which was treated nonoperatively. There were 96 patients who underwent nonunion. Putative intrinsic (patient-related) and extrinsic (injured-related) risk factors associated with nonunion were determined with the use of bivariate and multivariate statistical analyses.
RESULTS: By bivariate analysis, the risk of nonunion was significantly increased by several intrinsic risk factors including age, sex, and smoking and extrinsic risk factors including displacement of the fracture and the presence of comminution (P<0.05 for all). On multivariate analysis, smoking (OR=4.16, 95% CI: 1.01-14.16), fracture displacement (OR=7.81, 95% CI: 2.27-25.38) and comminution of fracture (OR=3.86, 95% CI: 1.16-13.46) were identified as independent predictive factors.
CONCLUSION: The risk factors for nonunion after nonoperative treatment of midshaft clavicle fractures are multifactorial. Smoking, fracture displacement and comminution of fracture are independent predictors for an individual likelihood of nonunion. Further studies are still required to evaluate these factors in the future. LEVEL OF EVIDENCE: Level III, case-control study.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Clavicle fracture; Multivariate analysis; Nonunion; Risk factor; Treatment

Mesh:

Year:  2015        PMID: 25703151     DOI: 10.1016/j.otsr.2014.11.018

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  6 in total

1.  Management of Displaced Midshaft Clavicle Fractures with Figure-of-Eight Bandage: The Impact of Residual Shortening on Shoulder Function.

Authors:  Carlo Biz; Davide Scucchiari; Assunta Pozzuoli; Elisa Belluzzi; Nicola Luigi Bragazzi; Antonio Berizzi; Pietro Ruggieri
Journal:  J Pers Med       Date:  2022-05-07

2.  [Clavicular fractures : Diagnostics, management and treatment].

Authors:  M Wurm; M Beirer; P Biberthaler; C Kirchhoff
Journal:  Unfallchirurg       Date:  2018-12       Impact factor: 1.000

3.  Fixation of comminuted midshaft clavicle fractures with bone fragments separated by soft tissue using a novel double ligature technique: A case report.

Authors:  Wei-Na Ju; Cheng-Xue Wang; Tie-Jun Wang; Bao-Chang Qi
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 4.  Fracture, nonunion and postoperative infection risk in the smoking orthopaedic patient: a systematic review and meta-analysis.

Authors:  Maria Anna Smolle; Lukas Leitner; Nikolaus Böhler; Franz-Josef Seibert; Mathias Glehr; Andreas Leithner
Journal:  EFORT Open Rev       Date:  2021-11-19

Review 5.  Do smokers have greater risk of delayed and non-union after fracture, osteotomy and arthrodesis? A systematic review with meta-analysis.

Authors:  R G Pearson; R G E Clement; K L Edwards; B E Scammell
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

6.  Clavicle fracture nonunion in the paediatric population: a systematic review of the literature.

Authors:  K Hughes; J Kimpton; R Wei; M Williamson; A Yeo; M Arnander; Y Gelfer
Journal:  J Child Orthop       Date:  2018-02-01       Impact factor: 1.548

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.